Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

OneMedNet (ONMD) Shares Outstanding (2021 - 2025)

OneMedNet has reported Shares Outstanding over the past 5 years, most recently at $52.0 million for Q4 2025.

  • Quarterly Shares Outstanding rose 84.5% to $52.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.0 million through Dec 2025, up 84.5% year-over-year, with the annual reading at $52.0 million for FY2025, 84.5% up from the prior year.
  • Shares Outstanding was $52.0 million for Q4 2025 at OneMedNet, up from $49.9 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $52.0 million in Q4 2025 and troughed at $585275.0 in Q1 2022.
  • The 5-year median for Shares Outstanding is $23.6 million (2023), against an average of $19.5 million.
  • Year-over-year, Shares Outstanding dropped 11.36% in 2022 and then surged 746.84% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $3.9 million in 2021, then decreased by 11.36% to $3.4 million in 2022, then skyrocketed by 590.07% to $23.6 million in 2023, then grew by 19.53% to $28.2 million in 2024, then soared by 84.5% to $52.0 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Shares Outstanding are $52.0 million (Q4 2025), $49.9 million (Q3 2025), and $46.3 million (Q2 2025).